These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 17228173)

  • 1. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients.
    Saab G; Young DO; Gincherman Y; Giles K; Norwood K; Coyne DW
    Nephron Clin Pract; 2007; 105(3):c132-8. PubMed ID: 17228173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
    Blair D; Byham-Gray L; Lewis E; McCaffrey S
    J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high dose ergocalciferol in chronic kidney disease patients with 25-hydroxyvitamin D deficiency.
    Trakarnvanich T; Chalapipat O; Disthabanchong S; Kurathong S; Praditpornsilpa K; Stitchantrakul W; Chailurkit LO
    J Med Assoc Thai; 2010 Aug; 93(8):885-91. PubMed ID: 20718162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
    Zisman AL; Hristova M; Ho LT; Sprague SM
    Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
    Hiremath GS; Cettomai D; Baynes M; Ratchford JN; Newsome S; Harrison D; Kerr D; Greenberg BM; Calabresi PA
    Mult Scler; 2009 Jun; 15(6):735-40. PubMed ID: 19383644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
    Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis.
    Ross EA; Tian J; Abboud H; Hippensteel R; Melnick JZ; Pradhan RS; Williams LA; Hamm LL; Sprague SM
    Am J Nephrol; 2008; 28(1):97-106. PubMed ID: 17914251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D deficiency and associated factors in hemodialysis patients.
    Jean G; Charra B; Chazot C
    J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
    Del Valle E; Negri AL; Aguirre C; Fradinger E; Zanchetta JR
    Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation.
    Jean G; Souberbielle JC; Chazot C
    Nephrol Dial Transplant; 2009 Dec; 24(12):3799-805. PubMed ID: 19622574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients.
    Capuano A; Serio V; Pota A; Memoli B; Andreucci VE
    J Nephrol; 2009; 22(1):59-68. PubMed ID: 19229819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very high-dose ergocalciferol is effective for correcting vitamin D deficiency in children and young adults with cystic fibrosis.
    Boas SR; Hageman JR; Ho LT; Liveris M
    J Cyst Fibros; 2009 Jul; 8(4):270-2. PubMed ID: 19447079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women.
    Prince RL; Austin N; Devine A; Dick IM; Bruce D; Zhu K
    Arch Intern Med; 2008 Jan; 168(1):103-8. PubMed ID: 18195202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Weekly high-dose ergocalciferol to correct vitamin D deficiency/insufficiency in hemodialysis patients: a pilot trial.
    Del Valle E; Negri AL; Fradinger E; Canalis M; Bevione P; Curcelegui M; Bravo M; Puddu M; Marini A; Ryba J; Peri P; Rosa Diez G; Sintado L; Gottlieb E
    Hemodial Int; 2015 Jan; 19(1):60-5. PubMed ID: 25231816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis.
    St Peter WL; Li S; Liu J; Gilbertson DT; Arneson TJ; Collins AJ
    Pharmacotherapy; 2009 Feb; 29(2):154-64. PubMed ID: 19170585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of preoperative vitamin D deficiency after Roux-en-Y gastric bypass surgery.
    Nelson ML; Bolduc LM; Toder ME; Clough DM; Sullivan SS
    Surg Obes Relat Dis; 2007; 3(4):434-7. PubMed ID: 17400028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
    Leventis P; Kiely PD
    Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current treatment recommendations for correcting vitamin D deficiency in pediatric patients with cystic fibrosis are inadequate.
    Green D; Carson K; Leonard A; Davis JE; Rosenstein B; Zeitlin P; Mogayzel P
    J Pediatr; 2008 Oct; 153(4):554-9. PubMed ID: 18589445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk in dosing regimens for 25-OH vitamin D supplementation in chronic haemodialysis patients.
    Albalate M; de la Piedra C; Ortiz A; Hernández Pérez J; Rubert M; Pérez Garcia R; Zazo P; Nieto L; de Sequera P; Egido J
    Nephron Clin Pract; 2012; 121(3-4):c112-9. PubMed ID: 23221739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.